Have the serotonin-dopamine antagonists rendered traditional antipsychotic agents obsolete?
Goff
D C
DC
Freedom Trail Clinic, Boston, MA 02114, USA.
D014150:Antipsychotic Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D010349:Patient Compliance; D018967:Risperidone / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D012702:Serotonin Antagonists; D018967:Risperidone